Anna Hoffmann
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in ⓘ
-
- Protease and Inhibitor Mechanisms 7
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- F Markwárdt (11 shared papers)F. Siepmann (1 shared paper)Juergen Siepmann (1 shared paper)B. Leclercq (1 shared paper)Brian Carlin (1 shared paper)H.‐P. Klöcking (7 shared papers)B Terhaag (3 shared papers)Holger H. Sigusch (4 shared papers)
In The Last Decade
Anna Hoffmann
36 papers receiving 393 citations
Peers
Comparison fields: 5 of 91
- Pharmaceutical Science 89
- Pharmacology 90
- Analytical Chemistry 45
- Hematology 41
- Pharmacology 57
Countries citing papers authored by Anna Hoffmann
This map shows the geographic impact of Anna Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hoffmann more than expected).
Fields of papers citing papers by Anna Hoffmann
This network shows the impact of papers produced by Anna Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hoffmann. The network helps show where Anna Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 86 | |
| 2 | 1970 | 41 | |
| 3 | Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects. | 1994 | 34 |
| 4 | 2003 | 30 | |
| 5 | Isolation and characterization of a thrombin inhibitor from the tick ixodes ricinus. | 1991 | 29 |
| 6 | 2002 | 26 | |
| 7 | 1983 | 19 | |
| 8 | Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation. | 1994 | 19 |
| 9 | 2000 | 18 | |
| 10 | 2021 | 18 | |
| 11 | 1985 | 15 | |
| 12 | In vitro investigations of drug release and penetration--enhancing effect of ultrasound on transmembrane transport of flufenamic acid. | 1998 | 13 |
| 13 | 1998 | 12 | |
| 14 | 1987 | 10 | |
| 15 | Dipyrone and diclofenac do not influence creatinine-clearance, inulin-clearance or PAH-clearance in healthy male volunteers. | 1995 | 6 |
| 16 | 1991 | 5 | |
| 17 | 1990 | 4 | |
| 18 | 1987 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2002 | 3 |
About Anna Hoffmann
Anna Hoffmann is a scholar working on Cancer Research, Pharmacology, Hematology, Surgery and Molecular Biology, having authored 38 papers that have together received 421 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Enzyme Production and Characterization (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Analytical Methods in Pharmaceuticals (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Pharmaceutical Science (89 citations), Pharmacology (90 citations), Analytical Chemistry (45 citations), Hematology (41 citations) and Pharmacology (57 citations). Anna Hoffmann has collaborated with scholars based in Germany, Czechia and France. Frequent co-authors include F Markwárdt, F. Siepmann, Juergen Siepmann, B. Leclercq, Brian Carlin, H.‐P. Klöcking, B Terhaag, Holger H. Sigusch, Marion Hippius and Werner Siegmund. Their work appears in journals such as Thrombosis Research, Journal of Pharmaceutical Sciences, Scientific Reports, Journal of Cystic Fibrosis and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.